ABSTRACT
PURPOSE: To assess doses variabilities in the same abdomen and chest RX exams for adults, to check the need for dose harmonization. To calculate Diagnostic Reference Levels (DRL), mandatory in the European Union, for the Algarve district in Portugal. Our results can be a valuable reference for the Portuguese official determination of DRLs, still in progress. METHOD: We considered 4,936 abdomen and 41,320 chest radiographs of adults, covering 7 health centres and 35 radiographers in Algarve. Entrance skin dose (ESD) was calculated for each radiograph and the corresponding uncertainty estimated. Mean doses per centre and per technician, and their uncertainties, were calculated to access dose variabilities. DRLs, set at the 3rd quartile of the total ESD distribution, were determined for a standard patient and for intervals of body mass index (BMI) to study their correlation with patient anatomical variations. Standard quartile errors were estimated. RESULTS: Our results suggest significant dispersion in applied ESDs among different centres and radiographers. Estimates of DRLs also show small fluctuations across years and an important dependence on BMI intervals. For a standard patient, they are 8.7 ± 0.1 (abdomen) and 0.44 ± 0.01 (chest), while the European DRLs are, respectively, 5.1 and 0.2 (all in mGy). CONCLUSIONS: Results suggest that there is room for dose optimization and harmonization with European DRLs, urging a national dose survey and the establishment of official national DRLs. Official DRLs in intervals of BMI would be quite beneficial, to avoid unnecessary dose exposures.
Subject(s)
Abdomen , Diagnostic Reference Levels , Adult , Humans , Portugal/epidemiology , Radiation Dosage , Radiography , Abdomen/diagnostic imaging , Reference ValuesABSTRACT
INTRODUCTION: Alexithymia is a neuropsychiatric symptom conceptualized as difficulty identifying and describing feelings. Although associated with other non-motor symptoms, mainly neuropsychiatric, alexithymia may present as an isolated symptom in persons with Parkinson's Disease (PwP). The objective of the study is to identify determinants of alexithymia and its association with quality of life (QoL) in Parkinson's disease. METHODS: Subjects with Parkinson's disease were recruited. The following instruments were applied: Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Non-Motor Symptoms Scale (NMSS), Montreal Cognitive Assessment (MoCA), Toronto alexithymia scale (TAS-20) and Parkinson's Disease Questionnaire (PDQ-8). Matched healthy controls were screened using TAS-20. Clinical and demographical variables were compared between alexithymic and non-alexithymic. Regression models were used to find determinants of alexithymia. Impact of alexithymia on QoL was estimated with a linear regression model. RESULTS: 98 patients were included. 56.1% PwP and 28.8% controls were alexithymic (p<0.001). Education level (OR 0.86) and NMSS urinary score (OR 1.09) determined alexithymia as well as TAS-20 score. Alexithymia was an independent determinant of QoL. CONCLUSIONS: Alexithymia is a prevalent independent non-motor symptom in PwP with impact on QoL. Low education level and urinary symptoms are important determinants of alexithymia.
Subject(s)
Parkinson Disease , Humans , Parkinson Disease/complications , Parkinson Disease/psychology , Affective Symptoms/complications , Affective Symptoms/diagnosis , Affective Symptoms/psychology , Quality of Life/psychology , Mental Status and Dementia Tests , Surveys and QuestionnairesABSTRACT
Introduction: Alexithymia is a neuropsychiatric symptom conceptualized as difficulty iden-tifying and describing feelings. Although associated with other non-motor symptoms, mainlyneuropsychiatric, alexithymia may present as an isolated symptom in persons with ParkinsonsDisease (PwP). The objective of the study is to identify determinants of alexithymia and itsassociation with quality of life (QoL) in Parkinsons disease. Methods: Subjects with Parkinsons disease were recruited. The following instruments wereapplied: Movement Disorders Society Unified Parkinsons Disease Rating Scale (MDS-UPDRS),Non-Motor Symptoms Scale (NMSS), Montreal Cognitive Assessment (MoCA), Toronto alexithymiascale (TAS-20) and Parkinsons Disease Questionnaire (PDQ-8). Matched healthy controls werescreened using TAS-20. Clinical and demographical variables were compared between alex-ithymic and non-alexithymic. Regression models were used to find determinants of alexithymia.Impact of alexithymia on QoL was estimated with a linear regression model.Results: 98 patients were included. 56.1% PwP and 28.8% controls were alexithymic (p < 0.001).Education level (OR 0.86) and NMSS urinary score (OR 1.09) determined alexithymia as well asTAS-20 score. Alexithymia was an independent determinant of QoL. Conclusions: Alexithymia is a prevalent independent non-motor symptom in PwP with impacton QoL. Low education level and urinary symptoms are important determinants of alexithymia.(AU)
Introducción: La alexitimia es un rasgo neuropsiquiátrico conceptualizado como la dificul-tad para identificar y describir sentimientos. Aunque está asociado con otros síntomas nomotores, principalmente neuropsiquiátricos, sigue siendo una característica independiente delas personas con enfermedad de Parkinson (PcP). El objetivo del estudio es identificar losdeterminantes de la alexitimia y su asociación con la calidad de vida en la enfermedad deParkinson. Métodos: Se reclutaron sujetos con enfermedad de Parkinson. Se aplicaron los siguientesinstrumentos: escala unificada de la enfermedad de Parkinson de la Sociedad de Trastornosdel Movimiento (MDS-UPDRS), escala de síntomas no motores (NMSS), evaluación cognitiva deMontreal (MoCA), escala de alexitimia de Toronto (TAS-20) y cuestionario de la enfermedadde Parkinson (PDQ-8). Se incluyeron controles sanos pareados, los cuales se evaluaron usandola TAS-20. Las variables clínicas y demográficas se compararon entre pacientes alexitímicos yno alexitímicos. Se utilizaron modelos de regresión para estimar los predictores de alexitimia.El impacto de este rasgo neuropsiquiátrico en la calidad de vida se estimó con un modelo deregresión lineal. Resultados: Se incluyeron 98 pacientes. El 56,1% de PcP y el 28,8% de los controles fueronalexitímicos (p < 0,001). El nivel educativo (OR 0,86) y la puntuación urinaria del NMSS (OR1,09) determinaron la alexitimia, así como la puntuación del TAS-20. La alexitimia fue undeterminante independiente de calidad de vida. Conclusiones: La alexitimia es un síntoma independiente no motor prevalente con impactoen la calidad de vida. El bajo nivel educativo y los síntomas urinarios son determinantesimportantes de esta condición. (AU)
Subject(s)
Humans , Quality of Life , Parkinson Disease , Affective Symptoms , Movement Disorders , Risk Factors , Neurology , Nervous System DiseasesABSTRACT
INTRODUCTION: Alexithymia is a neuropsychiatric symptom conceptualized as difficulty identifying and describing feelings. Although associated with other non-motor symptoms, mainly neuropsychiatric, alexithymia may present as an isolated symptom in persons with Parkinson's Disease (PwP). The objective of the study is to identify determinants of alexithymia and its association with quality of life (QoL) in Parkinson's disease. METHODS: Subjects with Parkinson's disease were recruited. The following instruments were applied: Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Non-Motor Symptoms Scale (NMSS), Montreal Cognitive Assessment (MoCA), Toronto alexithymia scale (TAS-20) and Parkinson's Disease Questionnaire (PDQ-8). Matched healthy controls were screened using TAS-20. Clinical and demographical variables were compared between alexithymic and non-alexithymic. Regression models were used to find determinants of alexithymia. Impact of alexithymia on QoL was estimated with a linear regression model. RESULTS: 98 patients were included. 56.1% PwP and 28.8% controls were alexithymic (p<0.001). Education level (OR 0.86) and NMSS urinary score (OR 1.09) determined alexithymia as well as TAS-20 score. Alexithymia was an independent determinant of QoL. CONCLUSIONS: Alexithymia is a prevalent independent non-motor symptom in PwP with impact on QoL. Low education level and urinary symptoms are important determinants of alexithymia.
ABSTRACT
Background: Meat is an important source of nutrients. However, in recent years their consumption is associated with chronic-degenerative diseases giving it the perception of "unhealthy food" Given that meat is an affordable source of quality protein; its improvement entails a huge challenge for the industry and science. Methods: The search and structured review of the literature in the last ten years in the scientific databases of articles related to the elaboration of restructured meat products with functional ingredients derived from plants. Objective: This work presents a general overview, as well as the most representative studies on the elaboration of restructured meat with ingredients from plants considered functional. Conclusions: The present review is intended to emphasize the use of plant natural ingredients in the elaboration of functional restructured meat products as an alternative for consumers allowing the inclusion of functional compounds beneficial to human health in their daily diet
Antecedentes: La carne es una fuente importante de nutrientes. Sin embargo, en los últimos años su consumo se asocia a enfermedades crónico-degenerativas dando la percepción de alimento poco saludable. Dado a que es una fuente accesible de proteína de calidad, su mejoramiento implica un enorme desafío para la industria y la ciencia de la carne. Método: La revisión estructurada de diversos artículos de investigación encontrados en bases de datos científicas, durante los últimos 10 años, relacionados a la elaboración de reestructurados cárnicos con derivados de plantas considerados funcionales. Objetivo: Este trabajo presenta una revisión general, de los estudios más representativos sobre la elaboración reestructurados cárnicos elaborados con derivados de plantas considerados como funcionales. Conclusión: La elaboración de productos reestructurados cárnicos funcionales con la utilización de derivados vegetales, puede considerarse una alternativa para los consumidores a fin de incluir compuestos funcionales beneficiosos para la salud humana en la dieta diaria
Subject(s)
Humans , Meat , Dietary Fiber , Fruit and Vegetable Juices , AntioxidantsABSTRACT
BACKGROUND: The aim of this study was to evaluate labor and delivery outcomes in parturients with inadvertent dural puncture managed by either insertion of an intrathecal catheter or a resited epidural catheter. METHODS: This was a retrospective cohort review of 235 parturients who had an inadvertent dural puncture during epidural placement over a six-year period. The primary outcome was the proportion of women with a delayed second stage of labor. Secondary outcomes were the proportion of cesarean deliveries, the proportion of cases resulting in post-dural puncture headache, and the incidence of failed labor analgesia. RESULTS: Baseline characteristics such as age, body mass index and parity were similar between the two groups. Among the 236 cases of inadvertent dural puncture, 173 women (73%) had an intrathecal catheter placed while 63 women (27%) had the epidural catheter resited. Comparing intrathecal with epidural catheters, there was no observed difference in the proportion of cases of prolonged second stage of labor (13% vs. 16%, P=0.57) and the overall rate of cesarean deliveries (17% vs. 16%, P=0.78). However, we observed a lower rate of post-dural puncture headache in women who had cesarean delivery compared to vaginal delivery (53% vs. 74%, P=0.007). A greater proportion of failed labor analgesia was observed in the intrathecal catheter group (14% vs. 2%, P=0.005). CONCLUSION: The choice of neuraxial technique following inadvertent dural puncture does not appear to alter the course of labor and delivery. Cesarean delivery decreased the incidence of post-dural puncture headache by 35%. Intrathecal catheters were associated with a higher rate of failed analgesia.
Subject(s)
Analgesia, Obstetrical/adverse effects , Anesthesia, Epidural/adverse effects , Dura Mater/injuries , Adult , Cohort Studies , Female , Humans , Post-Dural Puncture Headache/prevention & control , Pregnancy , Pregnancy Outcome , Retrospective Studies , Spinal Puncture/adverse effectsABSTRACT
Introducción: La enfermedad de Parkinson impacta en la calidad de vida del sujeto que la presenta, pero también ocasiona una carga para el cuidador. Los factores relacionados con estos efectos incluyen aspectos motores y no motores de la enfermedad, así como características inherentes al cuidador. Métodos: Se evaluó a sujetos con enfermedad de Parkinson mediante los siguientes instrumentos: cuestionario de calidad de vida PDQ-8, escala unificada de la enfermedad de Parkinson de la Sociedad de Trastornos del Movimiento parte i a iv (MDS-UPDRS) y estadio de Hoehn y Yahr (HY). A los cuidadores primarios, se les aplicó el inventario de carga del cuidador de Zarit. Adicionalmente, se registraron las principales variables demográficas y clínicas. Resultados: Se incluyó a 250 sujetos con enfermedad de Parkinson, de los cuales 201 contaban con un cuidador primario. En el análisis multivariado los factores predictores de una peor calidad de vida del sujeto con enfermedad de Parkinson fueron la puntuación de la MDS-UPDRS I (β = 0,39, p < 0,001), puntuación de la MDS-UPDRS II (β = 0,21, p < 0,001) y puntuación de la MDS-UPDRS III (β = 0,07, p = 0,004). En lo que respecta a la carga en el cuidador, la puntuación de la MDS-UPDRS II (β = 0,54, p = 0,007) fue el que más influyó. Conclusiones: El presente estudio muestra una relación entre la calidad de vida del sujeto con enfermedad de Parkinson y la percepción de carga del cuidador. No obstante, los factores que determinan cada una de estas parecen ser distintos
Introduction: Parkinson's disease affects the quality of life of the individual with the disease in addition to creating a burden on the caregiver. Factors related to these effects include motor and non-motor aspects of the disease, as well as traits inherent to the caregiver. Methods: We evaluated subjects with Parkinson's disease using the following instruments: Quality of Life Questionnaire PDQ-8, Movement Disorders Society Unified Parkinson's disease Rating Scale part i to iv (MDS-UPDRS), and Hoehn and Yahr staging. The Zarit Burden Inventory was used to assess all primary caregivers. Major demographic and clinical variables were also recorded. Results: A total of 250 subjects with Parkinson's disease were included, of whom 201 had a primary caregiver. In the multivariate analysis, predictors of poor quality of life for a subject with Parkinson's disease were the MDS-UPDRS I score (β = .39, P < .001), MDS-UPDRS II score (β = .21, P < .001), and MDS-UPDRS III score (β = .07, P = .004). Regarding caregiver burden, the MDS-UPDRS II score (β = .54, P = .007) was the most influential factor. Conclusions: The present study shows a relationship between quality of life for the subject with Parkinson's disease and the caregiver's perceived burden. However, the factors that determine each situation appear to be distinct
Subject(s)
Female , Humans , Male , Parkinson Disease/genetics , Parkinson Disease/nursing , Quality of Life/psychology , Caregivers/education , Caregivers/psychology , Primary Health Care , Primary Health Care/methods , Tourette Syndrome/metabolism , Parkinson Disease/complications , Parkinson Disease/metabolism , Quality of Life/legislation & jurisprudence , Caregivers/classification , Primary Health Care/classification , Primary Health Care/standards , Tourette Syndrome/complications , Tourette Syndrome/diagnosisABSTRACT
INTRODUCTION: Parkinson's disease affects the quality of life of the individual with the disease in addition to creating a burden on the caregiver. Factors related to these effects include motor and non-motor aspects of the disease, as well as traits inherent to the caregiver. METHODS: We evaluated subjects with Parkinson's disease using the following instruments: Quality of Life Questionnaire PDQ-8, Movement Disorders Society Unified Parkinson's disease Rating Scale part i to iv (MDS-UPDRS), and Hoehn and Yahr staging. The Zarit Burden Inventory was used to assess all primary caregivers. Major demographic and clinical variables were also recorded. RESULTS: A total of 250 subjects with Parkinson's disease were included, of whom 201 had a primary caregiver. In the multivariate analysis, predictors of poor quality of life for a subject with Parkinson's disease were the MDS-UPDRS I score (ß=.39, P<.001), MDS-UPDRS II score (ß=.21, P<.001), and MDS-UPDRS III score (ß=.07, P=.004). Regarding caregiver burden, the MDS-UPDRS II score (ß=.54, P=.007) was the most influential factor. CONCLUSIONS: The present study shows a relationship between quality of life for the subject with Parkinson's disease and the caregiver's perceived burden. However, the factors that determine each situation appear to be distinct.
Subject(s)
Caregivers , Parkinson Disease , Quality of Life , Adult , Aged , Caregivers/psychology , Cost of Illness , Female , Humans , Male , Middle Aged , Parkinson Disease/psychology , Psychiatric Status Rating Scales , Severity of Illness Index , Surveys and QuestionnairesABSTRACT
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron accumulation in the brain, because of mutations in the PANK2 gene. Phenotypic and genotypic characteristics of 11 patients from five Mexican families with PKAN disease are reported. Sequencing of PANK2 confirmed the diagnosis. The 11 patients had dysarthria associated with dystonia and Parkinsonism in six. Brain magnetic resonance imaging (MRI) showed the 'eye-of-the-tiger' sign in all patients. Three different mutations were identified, a novel one (p.A469P) and two (p.G219V and p.N404I) very rare. Homozygous sibs for the p.G219V mutation had a severe disease progression with early death. Dystonia predominated in the p.A469P/p.N404I compound heterozygous patients. Homozygous for p.N404I showed Parkinsonism, tics and personality and speech disorders. Early and late disease onset and variable expression was present in carriers of the different identified mutations. The 'eye-of-the-tiger' is an excellent neuroimaging hallmark to predict PANK2 mutations. We detected a 'cluster' of patients harboring the p.N404I mutation, strongly suggesting a founder effect for this mutation. This is the first familial clinical-genetic PKAN disease study accomplished in Mexico.
Subject(s)
Family , Magnetic Resonance Imaging , Pantothenate Kinase-Associated Neurodegeneration/diagnosis , Pantothenate Kinase-Associated Neurodegeneration/genetics , Adolescent , Brain/pathology , Child , Child, Preschool , Female , Founder Effect , Genetic Association Studies , Genotype , Humans , Male , Mexico , Mutation , Pedigree , Phenotype , Phosphotransferases (Alcohol Group Acceptor)/genetics , Sequence Analysis, DNAABSTRACT
BACKGROUND: We investigated both the efficacy and the sub-chronic toxicity of Tephrosia toxicariaâ Pers. in the zymosan-induced temporomandibular joint (TMJ) inflammatory hypernociception in rats evaluating the possible role of heme oxygenase-1 (HO-1). METHODS: Rats were pretreated with T. toxicaria (0.2, 2.0 or 20 mg/kg) 60 min before the intra-articular injection of zymosan (2 mg, 40 µL) in the left TMJ. In another series of experiments, rats were treated with ZnPP-IX (3 mg/kg), a specific HO-1 inhibitor, before T. toxicaria (20 mg/kg). Von Frey test was used to evaluate inflammatory hypernociception (g) 4 h after zymosan injection. Six hours after zymosan injection, the synovial lavage was collected for total cell count and myeloperoxidase (MPO) activity, and joint tissue for histopathological analysis and immunohistochemistry for HO-1. To evaluate the sub-chronic toxicity, mice received T. toxicaria (20 mg/kg) or saline once a day for 14 days to analyse body mass, organ weight and biochemical parameters. RESULTS: T. toxicaria partially reversed the zymosan-induced head withdrawal threshold, the number of cells and the MPO activity. T. toxicaria reduced the inflammatory cell influx in the synovial membrane. TMJ immunohistochemical analyses treated with T. toxicaria showed increased HO-1 expression. These effects of T. toxicaria were not observed in the presence of ZnPP-IX. T. toxicaria treatment for 14 days did not show significant signs of toxicity when administrated to mice. CONCLUSIONS: T. toxicaria did not produce any signs of toxicity and effectively decreased zymosan-induced TMJ inflammatory hypernociception dependent, at least in part, upon the HO-1 pathway integrity.
Subject(s)
Heme Oxygenase-1/metabolism , Hyperalgesia/drug therapy , Phytotherapy , Plant Preparations/pharmacology , Temporomandibular Joint Disorders/drug therapy , Tephrosia , Animals , Disease Models, Animal , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Heme Oxygenase-1/antagonists & inhibitors , Hyperalgesia/chemically induced , Inflammation/chemically induced , Inflammation/drug therapy , Male , Metabolic Networks and Pathways , Mice , Plant Preparations/administration & dosage , Plant Preparations/adverse effects , Protoporphyrins/administration & dosage , Protoporphyrins/pharmacology , Rats , Rats, Wistar , Temporomandibular Joint Disorders/chemically induced , Temporomandibular Joint Disorders/physiopathology , Zymosan/pharmacologyABSTRACT
It is not clear whether the presence of human papillomavirus (HPV) in squamous cell carcinomas of the tongue (SCCT) is of etiopathogenic and clinical significance. This study was designed to establish the incidence of HPV in SCCT and to determine the influence of HPV detection on clinical parameters and the prognosis. Clinical and histopathological data of 64 patients with SCCT were collected. Thirty benign lesions of the tongue were analyzed in parallel, in order to compare the HPV incidence and genotypes in these lesions with those of SCCT. Paraffin blocks of all cases were collected and PCR was carried out using SPF10 primers and the INNO-LiPA genotyping methodology. HPV was detected in 26.2% of the patients. Hybridization results showed that all patients except one had high-risk (HR)-HPV. HPV56 was the most common (42.1%), followed by HPV18 (26.3%), HPV16 (10.5%), HPV66 (10.5%), HPV39 (5.3%), and HPV51 (5.3%). The odds ratio of HR-HPV infection in cases vs. controls was statistically significant (9.45, 95% confidence interval 1.18-75.46). Among the results of the univariate analysis correlating the presence of HR-HPV with different clinical parameters, only mortality showed a statistically significant correlation, being higher in HR-HPV patients (odds ratio 3.97, 95% confidence interval 1.07-14.7).
Subject(s)
Carcinoma, Squamous Cell/virology , Carcinoma/virology , Papillomaviridae/isolation & purification , Papillomavirus Infections/diagnosis , Tongue Neoplasms/virology , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/therapy , Female , Genotype , Humans , Incidence , Male , Middle Aged , Papillomavirus Infections/epidemiology , Polymerase Chain Reaction , Prognosis , Registries , Retrospective Studies , Risk Factors , Survival Rate , Tongue Neoplasms/therapyABSTRACT
El presente artículo tiene como objetivo actualizar los conocimientos sobre las alteraciones morfológicas sobre las alteraciones morfológicas de las células epiteliales de la mucosa bucal de pacientes con diabetes tipo II, detectables con microscopía óptica y citología exfoliativa, con la finalidad de aportar datos que podrían ser útiles para el médico u odontólogo, junto a los análisis clínicos, para el diagnóstico precoz de esta enfermedad. Para una mejor comprensión y por la importancia de esta patología sistémica, se abordan los siguientes ítems: 1- diabetes mellitus tipo II y su impacto social, 2- diabetes mellitus tipo II y sus manifestaciones bucales, 3- citología bucal como método auxiliar del diagnóstico clínico. Los investigadores coinciden en que la diabetes causa alteraciones estructurales, morfológicas y morfométricas en las células bucales, fácilmente detectables por citología exfoliativa, por lo que esta técnica es viable para complementar el diagnóstico clínico y seguir la evolución de esta enfermedad.
Subject(s)
Humans , Male , Female , Cytological Techniques , Diagnosis, Oral , /diagnosis , Psychosocial Impact , Clinical Diagnosis/methods , Mouth Mucosa/pathology , Oral ManifestationsABSTRACT
El presente artículo tiene como objetivo actualizar los conocimientos sobre las alteraciones morfológicas sobre las alteraciones morfológicas de las células epiteliales de la mucosa bucal de pacientes con diabetes tipo II, detectables con microscopía óptica y citología exfoliativa, con la finalidad de aportar datos que podrían ser útiles para el médico u odontólogo, junto a los análisis clínicos, para el diagnóstico precoz de esta enfermedad. Para una mejor comprensión y por la importancia de esta patología sistémica, se abordan los siguientes ítems: 1- diabetes mellitus tipo II y su impacto social, 2- diabetes mellitus tipo II y sus manifestaciones bucales, 3- citología bucal como método auxiliar del diagnóstico clínico. Los investigadores coinciden en que la diabetes causa alteraciones estructurales, morfológicas y morfométricas en las células bucales, fácilmente detectables por citología exfoliativa, por lo que esta técnica es viable para complementar el diagnóstico clínico y seguir la evolución de esta enfermedad.(AU)
Subject(s)
Humans , Male , Female , Diabetes Mellitus, Type 2/diagnosis , Diagnosis, Oral , Cytological Techniques , Psychosocial Impact , Oral Manifestations , Mouth Mucosa/pathology , Clinical Diagnosis/methodsABSTRACT
Introducción: la relación de la lateralidad y asimetría de la enfermedad de Parkinson con la sintomatología de disfunción no motora ha sido abordada principalmente desde el punto de vista de las funciones cognitivas, y los escasos estudios que han involucrado otros síntomas han sido contradictorios. La asociación de los síntomas no motores con el tipo de inicio de la enfermedad no ha sido estudiada profundamente. Objetivo: analizar la asociación entre el lado de inicio de la sintomatología motora, así como del tipo de inicio termorígeno y rígido-bradicinético y la prevalencia de síntomas no motores. Pacientes y métodos: se incluyeron 232 pacientes con diagnóstico de enfermedad de Parkinson. Se documentó el tipo de inicio y el hemicuerpo afectado inicialmente. La presencia de síntomas no motores se determinó mediante la aplicación del cuestionario de síntomas no motores (NMSQuest). Resultados: al analizar el lado de inicio y la presencia de los síntomas no motores explorados se encontraron diferencias estadísticamente significativas en la frecuencia de alucinaciones (p=0,04) y del trastorno conductual del sueño (p<0,01) en los sujetos de inicio del lado derecho. En el caso del tipo de inicio no se encontraron diferencias con significación estadística. Conclusiones: los sujetos con inicio en el hemicuerpo derecho parecen tener un mayor riesgo de presentar tanto alucinaciones como trastorno conductual del sueño. El médico tratante debe buscar de forma intencionada estos síntomas en estos pacientes, y de esta manera otorgar un tratamiento adecuado que impacte en la calidad de vida de los mismos (AU)
Introduction: The relationship between laterality and asymmetry of Parkinson's disease and non-motor dysfunction has been studied mainly from the perspective of cognitive functions, and the few studies that have included other symptoms have mixed reports. The relationship between non-motor symptoms and the type of onset of the disease has not been studied in detail. Objective: to analyse the association between the side and type of motor onset and the prevalence of non-motor symptoms. Patients and methods: we included 232 patients diagnosed with Parkinson's disease. Type of onset and the side initially affected were documented. The presence of non-motor symptoms was determined by applying the non-motor symptom questionnaire (NMSQuest). Results: when analysing the side of onset and presence of each non-motor symptom explored, statistically significant differences were found in the frequency of hallucinations (P=0.04) and sleep behaviour disorder (P<0.01) in subjects with right side onset. The motor type of onset differences were not statistically significant. Conclusions: subjects with right side onset seem to have a higher risk of having hallucinations and sleep behaviour disorders. These symptoms should be intentionally sought in order to provide treatment and improve the patient's quality of life (AU)
Subject(s)
Humans , Parkinson Disease/complications , REM Sleep Behavior Disorder/epidemiology , Hallucinations/epidemiology , Parkinson Disease/physiopathology , Cerebrum/physiopathology , Functional Laterality , Muscle Rigidity/epidemiology , Tremor/epidemiologyABSTRACT
INTRODUCTION: the relationship between laterality and asymmetry of Parkinson's disease and non-motor dysfunction has been studied mainly from the perspective of cognitive functions, and the few studies that have included other symptoms have mixed reports. The relationship between non-motor symptoms and the type of onset of the disease has not been studied in detail. OBJECTIVE: to analyse the association between the side and type of motor onset and the prevalence of non-motor symptoms. PATIENTS AND METHODS: we included 232 patients diagnosed with Parkinson's disease. Type of onset and the side initially affected were documented. The presence of non-motor symptoms was determined by applying the non-motor symptom questionnaire (NMSQuest). RESULTS: when analysing the side of onset and presence of each non-motor symptom explored, statistically significant differences were found in the frequency of hallucinations (P=0.04) and sleep behaviour disorder (P<0.01) in subjects with right side onset. The motor type of onset differences were not statistically significant. CONCLUSIONS: subjects with right side onset seem to have a higher risk of having hallucinations and sleep behaviour disorders. These symptoms should be intentionally sought in order to provide treatment and improve the patient's quality of life.
Subject(s)
Functional Laterality , Movement Disorders/physiopathology , Parkinson Disease/physiopathology , Aged , Female , Hallucinations/etiology , Humans , Male , Middle Aged , Movement Disorders/etiology , Parkinson Disease/complications , Quality of Life , Sleep Wake Disorders/etiology , Surveys and QuestionnairesABSTRACT
(1)H and (13)C NMR chemical shifts of praecansone B, pongaflavone and dehydrorotenone isolated from Tephrosia egregia Sandw and obovatin from T. toxicaria Pers. were unambiguously assigned by 1D and 2D NMR experiments including (1)H, (1)H COSY, gHMQC and gHMBC, allowing the correction of literature assignments.
Subject(s)
Flavones/chemistry , Flavonoids/chemistry , Protons , Tephrosia/chemistry , Carbon Isotopes , Flavonoids/isolation & purification , Magnetic Resonance Spectroscopy , Molecular Structure , Reference Standards , StereoisomerismABSTRACT
INTRODUCTION: Auto-antibody determinations are very important in current clinical practice, not only in immunology or rheumatology but also in the neurosciences. These antibodies have both diagnostic and prognostic implications which, unfortunately, are often overused or are granted undue importance when it comes to interpreting them. On requesting their determination it is therefore necessary to know their indications, utility and application. AIM: To present a series of auto-antibodies that are relatively commonly used in neurology and which have primary and secondary effects on both the central and the peripheral nervous system, including the neuromuscular junction and muscle tissue. DEVELOPMENT: In this review we cover a series of different conditions, including diseases such as vasculitis, cerebrovascular disease, neurological paraneoplastic syndromes, dysimmune polyneuropathies and inflammatory myopathies. Special attention is given, when relevant, to the indications and, particularly, to the value and weight that should be granted to both positive and negative results. CONCLUSIONS: Appropriate interpretation and knowledge of the scope and limitations of auto-antibodies are essential, because otherwise they will lead to mistaken diagnoses and, consequently, erroneous treatment.
Subject(s)
Autoantibodies/analysis , Nervous System Diseases/diagnosis , Nervous System Diseases/immunology , Central Nervous System Diseases/diagnosis , Humans , Myositis/diagnosis , Paraneoplastic Syndromes, Nervous System/diagnosis , Peripheral Nervous System Diseases/diagnosis , Stroke/diagnosis , Vasculitis/diagnosisABSTRACT
Las determinaciones de autoanticuerpos son de gran relevancia en la práctica clínica actual, no sóloen las áreas de inmunología o reumatología, sino también en las neurociencias. Estos anticuerpos poseen implicaciones tanto diagnósticas como pronósticas, que desafortunadamente se sobreutilizan con gran frecuencia o se les da un valor inapropiado en la interpretación; por lo anterior, es necesario al solicitarlos conocer sus indicaciones, utilidad y aplicación.Objetivo. Presentar una serie de autoanticuerpos de uso relativamente frecuente en neurología y que afectan tanto de manera primaria como secundaria al sistema nervioso central y periférico, incluidos también la placa neuromuscular y el músculo.Desarrollo. A lo largo de esta revisión se cubre una serie de entidades diversas, entre las que se incluyen enfermedades como vasculitis, enfermedad vascular cerebral, síndromes paraneoplásicos neurológicos, polineuropatías disinmunes y miopatías inflamatorias. Se hace hincapié, cuando es pertinente, en las indicaciones y, particularmente, en el valor y peso que a suresultado, tanto positivo como negativo, se le debe otorgar. Conclusiones. La interpretación adecuada y el conocimiento del alcance y limitaciones de los autoanticuerpos son indispensables, ya que de lo contrario conducirán a errores en el diagnósticoy, como consecuencia, en el tratamiento
Introduction. Auto-antibody determinations are very important in current clinical practice, not only in immunology or rheumatology but also in the neurosciences. These antibodies have both diagnostic and prognostic implications which, unfortunately, are often overused or are granted undue importance when it comes to interpreting them. On requesting their determination it is therefore necessary to know their indications, utility and application. Aim. To present a series of autoantibodies that are relatively commonly used in neurology and which have primary and secondary effects on both the central and the peripheral nervous system, including the neuromuscular junction and muscle tissue. Development. In this review we cover a series of different conditions, including diseases such as vasculitis, cerebrovascular disease, neurological paraneoplastic syndromes, dysimmune polyneuropathies and inflammatory myopathies. Special attention is given, when relevant, to the indications and, particularly, to the value and weight that should be granted to both positive and negative results.Conclusions. Appropriate interpretation and knowledge of the scope and limitations of auto-antibodies are essential, because otherwise they will lead to mistaken diagnoses and, consequently, erroneous treatment
Subject(s)
Humans , Autoantibodies , Nervous System Diseases/diagnosis , Biomarkers/analysis , Autoimmunity/physiology , Diagnostic Errors/prevention & controlABSTRACT
Buschke-Löwenstein tumor or giant condyloma is a warty verrucous lesion, characterized by slow growth, locally infiltrating and disfiguring lesions. Despite its benign histological appearance and low risk of metastasis, Buschke-Löwenstein tumor is an intermediate lesion between condyloma acuminatum and verrucous carcinoma. It has been linked to human papilloma virus, mainly subtypes 6 and 11. Other factors implicated in this disease include poor hygiene, chronic irritation, promiscuity, and cellular immunocompromised states. It rarely occurs in children. The first line of treatment is radical surgical excision with or without adjuvant chemotherapy. We report the case of a 12-year-old girl with a giant perianal condyloma that was treated with surgical excision and a 6-week course of 5-fluorouracil beginning 6 weeks after surgery, with excellent functional and cosmetic results.
Subject(s)
Anus Neoplasms/drug therapy , Carcinoma, Verrucous/drug therapy , Condylomata Acuminata/drug therapy , Antimetabolites, Antineoplastic/therapeutic use , Anus Neoplasms/surgery , Carcinoma, Verrucous/surgery , Child , Condylomata Acuminata/surgery , Female , Fluorouracil/therapeutic use , Humans , Treatment OutcomeABSTRACT
A atividade larvicida de quatro saponinas monodesmosídicas (1-4) isoladas de Pentaclethra macroloba e de uma saponina bidesmosídica (5) isolada de Cordia piauhiensis foi avaliada sobre larvas de estágio 3 de Aedes aegypti. As larvas foram expostas a várias concentrações (500, 250, 100, 50, 25 e 12,5 mg/mL) das saponinas por um período de 24 h. Os resultados indicam que somente as saponinas 1-3 mostraram alta atividade larvicida, com CL50 variando de 18,6 a 27,9 mg/mL. Estes resultados ressaltam as potencialidades destas saponinas como possíveis agentes larvicidas naturais.
The larvicidal activity of the four monodesmoside saponins (1-4) isolated from Pentaclethra macroloba and one bidesmoside saponin (5) from Cordia piauhiensis was evaluated on 3rd instar larvae of Aedes aegypti. The larvae were exposed to serial concentrations (500, 250, 100, 50, 25 and 12.5 mg/mL) saponins for a period of 24 h. The results indicate that, only the saponins 1-3 showed high larvicidal activity, with LC50 ranging of 18,6-27,9 mg/mL. These results suggest that these can be used as natural larvicidal agents.
